## RKLB: Rocket Lab Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.8% below STRENGTH zone (3.0-6.0%); PEG 1.45 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-17.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($60.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Rocket Lab stock drops 8.5% in thin holiday trade â€” what investors watch next**
- Source: ts2.tech | 20251228T120919 | Somewhat-Bearish | Relevance: 100%
- Rocket Lab shares dropped 8.5% to $70.65 in a thin holiday trade session after pulling back from recent highs. This decline occurs as investors weigh the company's ability to translate its growing U.S. government defense satellite contracts into sustainable revenue and margins. Future investor attention will focus on whether the stock can hold the $70 level and the details within its next earnings report, expected around February 26, 2026.

**2. Rocket Lab Stock (RKLB) Weekend Update: Shares Cool After a Record Run as Analysts Lift Targets on $816M Space Force Contract**
- Source: ts2.tech | 20251228T100933 | Somewhat-Bullish | Relevance: 100%
- Rocket Lab Corporation (RKLB) shares have cooled after a significant December rally, driven by an $816 million Space Development Agency contract win for 18 satellites. Analysts have responded by raising price targets, emphasizing Rocket Lab's pivot from solely a launch company to a vertically integrated defense and space systems provider. Investors are now evaluating whether the recent pullback is a continuation of momentum or profit-taking after the stock's substantial run.

**3. Rocket Lab Shares Take a Breather After Stellar Run**
- Source: AD HOC NEWS | 20251230T100947 | Neutral | Relevance: 100%
- Rocket Lab USA's stock is experiencing a period of consolidation after exceptional gains, driven by a major government contract, record launches, and Neutron rocket progress. The market is weighing an elevated valuation against these achievements, leading to increased volatility. Technical analysis shows the stock is overbought but resilient, with the critical $68 to $70 range acting as a support zone for the near term.

**4. 519,235 Shares in Rocket Lab Corporation $RKLB Purchased by TB Alternative Assets Ltd.**
- Source: MarketBeat | 20251228T114933 | Somewhat-Bullish | Relevance: 100%
- TB Alternative Assets Ltd. recently acquired 519,235 shares of Rocket Lab Corporation (NASDAQ:RKLB) valued at $24.9 million, making it their 12th largest holding. This purchase comes amid significant insider selling by Rocket Lab executives, including CEO Peter Beck, who sold over 1.5 million shares. Rocket Lab has seen positive revenue growth and analyst ratings but is also experiencing a sector-wide pullback and anomalous short-interest data.

**5. Harbor Capital Advisors Inc. Invests $862,000 in Rocket Lab Corporation $RKLB**
- Source: MarketBeat | 20251228T111033 | Somewhat-Bearish | Relevance: 100%
- Harbor Capital Advisors Inc. acquired a new stake of 17,991 shares, valued at $862,000, in Rocket Lab Corporation during the third quarter. This investment comes amidst significant insider selling, including CEO Peter Beck's sale of 1.56 million shares, and a sector-wide pullback despite positive news regarding a potential $1 billion U.S. Space Development Agency deal. The company currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $61.25.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Needham | $90 | $63 | +43% |
| 2025-12-22 | Stifel | $85 | $75 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Needham | main | Buy |
| 2025-12-22 | Stifel | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 16 ($25.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.8% (+5.4%)
- Blackrock Inc.: 5.9% (+38.0%)
- Capital World Invest: 2.7% (+9.4%)
- State Street Corpora: 2.3% (+13.6%)
- BAILLIE GIFFORD & CO: 2.3% (+176.1%)

### Key Risks

1. High beta (2.21) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $26M sold (16 transactions in 90 days).
3. Elevated short interest (8.7%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.45 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 47% YoY. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($25.5M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 2.21 |
| 52W Range | $14.71 - $79.83 |
| Short Interest | 8.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.45 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 20.6% to 2.8% (-17.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.2pp (needs >3.0% for momentum thesis). MRS_5 (-3.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.31), confirming momentum. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.84% (CS: 98) | Neutral |
| RSI_14 | 63.0 | Neutral |
| MACD Histogram | 1.31 | Bullish |
| vs SMA20 | 1.163x | Above |
| vs SMA50 | 1.262x | Above |
| vs SMA200 | 1.713x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $70.45
- **Stop Loss:** $60.15 (14.6% risk)
- **Target:** $80.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $9,017.60
- **Portfolio %:** 9.02%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.10 | $-0.03 | +71.3% |
| 2025Q2 | $-0.11 | $-0.13 | -17.9% |
| 2025Q1 | $-0.12 | $-0.12 | +0.5% |
| 2024Q4 | $-0.10 | $-0.10 | -2.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*